The following represents disclosure information provided by authors of this abstract. The ASCO Scientific Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
Use of gene expression and alternative splicing signatures to discriminate breast cancer stem cells from fibroblasts.
David T. Weaver
Consultant or Advisory Role - Verastem
Irina M Shapiro
Stock Ownership - Verastem
Alan G Derr
Consultant or Advisory Role - Verastem
Daniel Paterson
Consultant or Advisory Role - Verastem
Jonathan A Pachter
Stock Ownership - Verastem